Clinical Trial

To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated October 17, 2024 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the preliminary efficacy, safety, tolerability and pharmacokinetics of KC1036 in participants with advanced recurrent or metastatic digestive system tumors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-02-18; most recent amendment 2024-10-15.
Status change: Not Yet Recruiting → Recruiting 2022-12-28
Trial Details
NCT Number NCT05260385
Lead Sponsor Beijing Konruns Pharmaceutical Co., Ltd.
Conditions Digestive System Tumors
Enrollment 133 participants
Start Date 2022-01-24
Primary Completion 2025-10-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-17